首页> The Journal of molecular diagnostics: JMD> Measurable Residual Disease Monitoring for Patients with Acute Myeloid Leukemia Following Hematopoietic Cell Transplantation Using Error-Corrected Hybrid-Capture Next-Generation Sequencing

Measurable Residual Disease Monitoring for Patients with Acute Myeloid Leukemia Following Hematopoietic Cell Transplantation Using Error-Corrected Hybrid-Capture Next-Generation Sequencing

导出原文传递

翻译打印收藏纠错

第一作者： Balagopal, V.

作者： Balagopal, V. ^[1] ; Hantel, A. ; Kadri, S. ; Steinhardt, G. ; Zhen, C. ; Kang, W. ; Wanjari, P. ; Ritterhouse, L. L. ; Stock, W. ; Segal, J. P.

作者单位： Univ Chicago, Chicago, IL 60637 USA ^[1]

发布时间 2020-11-17

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

The Journal of molecular diagnostics

2019年21卷6期

1149-1149页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

The Journal of molecular diagnostics

2019年21卷6期

1149-1149页

检索历史清除

Measurable Residual Disease Monitoring for Patients with Acute Myeloid Leukemia Following Hematopoietic Cell Transplantation Using Error-Corrected Hybrid-Capture Next-Generation Sequencing

The Journal of molecular diagnostics

相似文献

同项目论文

The Journal of molecular diagnostics

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Measurable Residual Disease Monitoring for Patients with Acute Myeloid Leukemia Following Hematopoietic Cell Transplantation Using Error-Corrected Hybrid-Capture Next-Generation Sequencing

The Journal of molecular diagnostics

相似文献

同项目论文

The Journal of molecular diagnostics

相关期刊

检索历史清除